Magrolimab in Combination With Azacitidine in Patients With Higher-Risk Myelodysplastic Syndromes: Final Results of a Phase Ib Study. (2023)

First Author: Sallman DA
Attributed to:  Biology and Treatment of Human Myeloid Cancers funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1200/jco.22.01794

PubMed Identifier: 36888930

Publication URI: http://europepmc.org/abstract/MED/36888930

Type: Journal Article/Review

Volume: 41

Parent Publication: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Issue: 15

ISSN: 0732-183X